PRONOVA BIOPHARMA NORGE AS V. TEVA PHARMACEUTICALS USA, INC. , No. 12-1498 (Fed. Cir. 2012)

Annotate this Case
Download PDF
Case: 12-1498 Document: 47 Page: 1 Filed: 12/27/2012 NOTE: This order is nonprecedential. United States Court of Appeals for the Federal Circuit __________________________ PRONOVA BIOPHARMA NORGE AS, Plaintiff-Appellee, v. TEVA PHARMACEUTICALS USA, INC., Defendant-Appellant, AND PAR PHARMACEUTICAL, INC. AND PAR PHARMACEUTICAL COMPANIES, INC., Defendants-Appellants. __________________________ 2012-1498, -1499 __________________________ Appeals from the United States District Court for the District of Delaware in consolidated case nos. 09-CV-0286 and 09-CV-0305, Judge Sue L. Robinson. __________________________ ON MOTION __________________________ ORDER Teva Pharmaceuticals USA, Inc. ( Teva ) and Par Pharmaceutical Companies, Inc. (collectively Par ) Case: 12-1498 Document: 47 Page: 2 Filed: 12/27/2012 PRONOVA BIOPHARMA NORGE V. TEVA PHARMACEUTICALS 2 jointly move for an extension of time, until January 16, 2013 to file their reply briefs. Upon consideration thereof, IT IS ORDERED THAT: (1) The December 19, 2012 motion is granted. (2) The December 13, 2012 motion is withdrawn. FOR THE COURT /s/ Jan Horbaly Jan Horbaly Clerk s27

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.